AS-1405

N/A

Report date: 2023/02/04 20:39:21

Base Information

Drug NameAS-1405

Drug Alias NameAS1405Yttrium 90 labelled monoclonal antibody BC1R 1405AngioMabY90 mBC1 +[7]

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody murineBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody diagnostics

Mechanisms of ActionAngiogenesis inhibitorsFibronectin inhibitors

TargetsFibronectin

Therapy Area/IndicationsGlioblastoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAntisoma

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAntisoma

Active IndicationsN/A

Inactive IndicationsGlioblastoma

Other Information

ATC CodeN/A